Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of fibrinogen concentrate in obstetric hemorrhage (SFOH study)
jRCTs031180414Completed
- Sponsor
- Mochida Pharmaceutical Co., Ltd.
- Start
- Jul 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of Fibrinogen human in postpartum hemorrhage (PPH) and hypofibrinogenemia, sponsored by Mochida Pharmaceutical Co., Ltd. Primary endpoint: Incidence of transfusion-associated circulatory overload (TACO). Started Jul 2016; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
postpartum hemorrhage (PPH)hypofibrinogenemia
Beyond the preview
Go deeper on jRCTs031180414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180414.